Andrea Forschner

39PUBLICATIONS
120CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyGene and molecular therapyEthical use of new technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jul 02, 2026
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

|Jul 01, 2026
Perioperative PD-1-inhibition in melanoma patients - a retrospective analysis from eight German skin cancer centers.

|Apr 09, 2026
Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarker.

Elena Sophia Lindner, Jakob Admard, German Demidov

|Mar 08, 2026
Tolerability and efficacy of chemosaturation in combination with systemic therapy for metastatic uveal melanoma.

Patrick Kasteleiner, Gerd Grözinger, Jörg Schmehl

|Dec 30, 2025
Multi-Omics Tumor Immunogenicity Score Predicts Immunotherapy Outcome and Survival.

Axel Gschwind, Nadja Ballin, Alexander Ott

|Nov 22, 2025
Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centers.

Markus Reitmajer, Elisabeth Livingstone, Lucie Heinzerling

Pageof 7

Frequent Collaborators

5 joint publications

Markus Reitmajer

5 joint publications

Claus Garbe

5 joint publications

Christoffer Gebhardt

4 joint publications

Patrick Terheyden